Comparison study data between Flow Cytometry antibodies from Elabscience, BioLegend and BD Biosciences.
Flow Cytometry Antibodies Comparison

Comparison study data between Flow Cytometry antibodies from Elabscience, BioLegend and BD Biosciences.
KACTUS have developed a dsRNA Quick-Quantification Kit to detect the presence of undesired dsRNA molecules in IVT reactions or dsRNA in viral/non-viral nucleic acid extracts.
KACTUS has carefully developed a highly sensitive spCas9 detection kit.
KACTUS’ AAV ELISA kits using recombinant monoclonal antibodies are developed using their proprietary immunisation scheme that overcomes the weak AAV immunogenicity.
KACTUS has developed a series of high-activity enzyme for in vitro synthesis of DNA vectors, based on their SAMS™ technology platform.
KACTUS have used their SAMS™ protein production platform to develop high-quality enzymes for in vitro synthesis of mRNA (GMP-Grade & GMP-Ready).
KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.
At KACTUS, they have developed a highly-active, wild-type Cas9 nuclease based on their SAMS™ technology platform.
AccuBase® is a cytosine base editor that converts a C-G base pair into a T-A base pair in the genome. Designed by Base Therapeutics, manufactured by KACTUS.
KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.